The accurate identification of HIV-specific T cell responses is important for determining the relationship between immune response, viral control, and disease progression. HIV-specific immune responses are usually measured using peptide sets based on consensus sequences, which frequently miss responses to regions where test set and infecting virus differ. In this study, we report the design of a peptide test set with significantly increased coverage of HIV sequence diversity by including alternative amino acids at variable positions during the peptide synthesis step. In an IFN-γ ELISpot assay, these "toggled" peptides detected HIV-specific CD4+ and CD8+ T cell responses of significantly higher breadth and magnitude than matched consensus pe...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
Since HLA-restricted cytotoxic T-cell responses select specific polymorphisms in HIV-1 sequences and...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...
The antigenic diversity of human immunodeficiency virus type 1 (HIV-1) represents a significant chal...
Increasing efforts are directed towards the development of effective vaccines through induction of v...
Delineation of the immune correlates of protection in natural infection or after vaccination is a ma...
The characterization of host immune responses to human immunodeficiency virus (HIV) in HIV controlle...
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed t...
An effective HIV vaccine will need to stimulate immune responses against the sequence diversity pres...
Full characterisation of functional HIV-1-specific T-cell responses, including identification of rec...
The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to identify vira...
<div><p>The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to ident...
<p>(A) Mapping of epitopes was done using pools of overlapping peptides. The peptides spanned the en...
<p>(A) Peptide pools containing the predicted CD4<sup>+</sup> T cell epitopes (NAE and AE forms) wer...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
Since HLA-restricted cytotoxic T-cell responses select specific polymorphisms in HIV-1 sequences and...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...
The antigenic diversity of human immunodeficiency virus type 1 (HIV-1) represents a significant chal...
Increasing efforts are directed towards the development of effective vaccines through induction of v...
Delineation of the immune correlates of protection in natural infection or after vaccination is a ma...
The characterization of host immune responses to human immunodeficiency virus (HIV) in HIV controlle...
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed t...
An effective HIV vaccine will need to stimulate immune responses against the sequence diversity pres...
Full characterisation of functional HIV-1-specific T-cell responses, including identification of rec...
The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to identify vira...
<div><p>The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to ident...
<p>(A) Mapping of epitopes was done using pools of overlapping peptides. The peptides spanned the en...
<p>(A) Peptide pools containing the predicted CD4<sup>+</sup> T cell epitopes (NAE and AE forms) wer...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
Since HLA-restricted cytotoxic T-cell responses select specific polymorphisms in HIV-1 sequences and...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...